

The field of sleep medicine witnessed substantial progress in 2025, spanning from new treatments for narcolepsy and sleep apnoea, and new guidelines for restless legs syndrome, to new imaging biomarkers of neurodegeneration emerging from the study of rapid-eye-movement sleep behaviour disorder (RBD). These advances strengthened the translational connections between molecular mechanisms and clinical neurology.
Neurology
|22nd Dec, 2025
|Journal of the American Medical Association
Neurology
|18th Dec, 2025
|Journal of the American Medical Association
Neurology
|17th Dec, 2025
|Journal of the American Medical Association
Neurology
|15th Jan, 2026
|The Lancet
Neurology
|15th Dec, 2025
|Journal of the American Medical Association
Neurology
|15th Jan, 2026
|Journal of the American Medical Association
Neurology
|15th Jan, 2026
|Journal of the American Medical Association